Advanced MRI in renal tumours

Advanced MRI in renal tumours - MRI in renal tumours

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON40717

Enrollment

Registered

2014-09-15

Start date

2014-10-08

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney cancer renal tumours

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Planned to undergo (partial) tumour nephrectomy of at least one untreated tumour of one kidney; - Signed IRB-approved informed consent form.

Exclusion criteria

Exclusion criteria: - Relative contra indications for MR imaging (metal device/foreign bodies, claustrophobia); - Known hypersensitivity / previous allergic reaction to gadolinium based contrast agent; - Active renal or perirenal infection; - Minor and/or incapacitated adult.

Design outcomes

Primary

Measure	Time frame
To assess the discriminative value of diffusion weighted MR imaging for malignant versus benign lesions.	—

Secondary

Measure	Time frame
To assess the discriminative value of DTI for histological subtype of renal tumours using DTI and Fractional Anisotrophy (FA) values.	—

Countries

Netherlands

Outcome results